NASDAQ:MDXH MDxHealth (MDXH) Stock Price, News & Analysis $0.75 +0.00 (+0.53%) Closing price 04:00 PM EasternExtended Trading$0.76 +0.01 (+1.46%) As of 04:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About MDxHealth Stock (NASDAQ:MDXH) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get MDxHealth alerts:Sign Up Key Stats Today's Range$0.72▼$0.7950-Day Range$0.75▼$3.3652-Week Range$0.68▼$5.33Volume590,592 shsAverage Volume364,656 shsMarket Capitalization$37.32 millionP/E RatioN/ADividend YieldN/APrice Target$4.63Consensus RatingModerate Buy Company Overview MDxHealth, headquartered in Mechelen, Belgium, with a U.S. presence in Newton, Massachusetts, is a molecular diagnostics company focused on improving the accuracy of cancer diagnosis and treatment decision making through epigenetic biomarker assays. The company specializes in developing and commercializing tests that detect DNA methylation changes associated with urological cancers, enabling more precise risk stratification and patient management. MDxHealth’s lead product portfolio includes ConfirmMDx and SelectMDx. ConfirmMDx is an epigenetic assay performed on prostate biopsy tissue to identify men at risk of harboring occult high-grade prostate cancer following a negative biopsy result. SelectMDx is a non-invasive urine test designed to assess the likelihood of clinically significant prostate cancer before an initial biopsy, helping to reduce unnecessary procedures. Both tests are performed in MDxHealth’s CLIA-certified laboratory in the United States and its ISO-certified laboratory in Europe, and are used by urologists worldwide to guide biopsy and treatment decisions. Founded in 2003, MDxHealth has established a global footprint, serving patients and healthcare providers across North America, Europe and select international markets through direct lab services and strategic partnerships. The company is led by President and CEO Caroline Palm, who brings extensive experience in molecular diagnostics and life sciences. MDxHealth is publicly traded on the Nasdaq under the ticker symbol MDXH.AI Generated. May Contain Errors. Read More MDxHealth Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks66th Percentile Overall ScoreMDXH MarketRank™: MDxHealth scored higher than 66% of companies evaluated by MarketBeat, and ranked 289th out of 869 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.3 / 5Analyst RatingModerate Buy Consensus RatingMDxHealth has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on no strong buy ratings, 4 buy ratings, 1 hold rating, and 1 sell rating.Upside PotentialMDxHealth has a consensus price target of $4.63, representing about 513.4% upside from its current price of $0.75.Amount of Analyst CoverageMDxHealth has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about MDxHealth's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for MDxHealth are expected to grow in the coming year, from ($0.60) to ($0.34) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of MDxHealth is -1.16, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of MDxHealth is -1.16, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Read more about MDxHealth's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.87% of the float of MDxHealth has been sold short.Short Interest Ratio / Days to CoverMDxHealth has a short interest ratio ("days to cover") of 0.57, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in MDxHealth has recently increased by 1,643.58%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldMDxHealth does not currently pay a dividend.Dividend GrowthMDxHealth does not have a long track record of dividend growth. News and Social Media3.1 / 5News Sentiment0.88 News SentimentMDxHealth has a news sentiment score of 0.88. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for MDxHealth this week, compared to 2 articles on an average week.Search Interest1 people have searched for MDXH on MarketBeat in the last 30 days. MarketBeat Follows1 people have added MDxHealth to their MarketBeat watchlist in the last 30 days. Company Ownership0.1 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, MDxHealth insiders have not sold or bought any company stock.Percentage Held by Insiders1.70% of the stock of MDxHealth is held by insiders.Percentage Held by InstitutionsMDxHealth has minimal institutional ownership at this time.Read more about MDxHealth's insider trading history. Receive MDXH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MDxHealth and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MDXH Stock News HeadlinesHead-To-Head Review: Predictive Oncology (NASDAQ:POAI) & MDxHealth (NASDAQ:MDXH)May 28 at 3:51 AM | americanbankingnews.comMDxHealth SA (MDXH) Q1 2026 Earnings Call TranscriptMay 14, 2026 | seekingalpha.comHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall of Fame Trader Jon Najarian now says EVERYONE is missing an even bigger story about the SpaceX IPO… That it's just the start of an Elon Musk $44 trillion "Superconvergence…" An event that could kick off as soon as June 12th.May 28 at 1:00 AM | Banyan Hill Publishing (Ad)MDxHealth SA (MDXH) Q1 2026 Earnings Call Highlights: Revenue Surge and Strategic Focus Amid ...May 14, 2026 | finance.yahoo.comMDxHealth (MDXH) Q1 2026 Earnings TranscriptMay 14, 2026 | fool.comMDxHealth Reports Q1 2026 Results: Full Earnings Call TranscriptMay 13, 2026 | finance.yahoo.comMdxhealth Reports Q1-2026 ResultsMay 13, 2026 | globenewswire.comMdxhealth to Release First Quarter 2026 Financial Results on May 13April 30, 2026 | globenewswire.comSee More Headlines MDXH Stock Analysis - Frequently Asked Questions How have MDXH shares performed this year? MDxHealth's stock was trading at $3.57 at the beginning of the year. Since then, MDXH stock has decreased by 78.9% and is now trading at $0.7540. How were MDxHealth's earnings last quarter? MDxHealth SA (NASDAQ:MDXH) released its earnings results on Wednesday, May, 13th. The company reported ($0.19) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.14) by $0.05. The company had revenue of $23.90 million for the quarter, compared to the consensus estimate of $30.89 million. MDxHealth had a negative trailing twelve-month return on equity of 1,078.01% and a negative net margin of 29.90%. Read the conference call transcript. When did MDxHealth's stock split? MDxHealth's stock reverse split on the morning of Friday, December 29th 2023.The 1-10 reverse split was announced on Monday, October 2nd 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, December 28th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. When did MDxHealth IPO? MDxHealth (MDXH) raised $45 million in an initial public offering on Thursday, November 4th 2021. The company issued 3,750,000 shares at a price of $12.00 per share. Who are MDxHealth's major shareholders? MDxHealth's top institutional shareholders include Perkins Capital Management Inc. (2.98%), Renaissance Technologies LLC (0.62%), Bank of America Corp DE (0.09%) and AlphaCentric Advisors LLC (0.07%). View institutional ownership trends. How do I buy shares of MDxHealth? Shares of MDXH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of MDxHealth own? Based on aggregate information from My MarketBeat watchlists, some other companies that MDxHealth investors own include Cognition Therapeutics (CGTX), LAVA Therapeutics (LVTX), PHX Minerals (PHX), PayPal (PYPL), Arcadia Biosciences (RKDA) and Alimera Sciences (ALIM). Company Calendar Last Earnings5/13/2026Today5/28/2026Next Earnings (Estimated)8/13/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (2m+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 MDXH's financial health is in the Red zone, according to TradeSmith. MDXH has been in this zone for over 2 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MEDICAL INFO SYS Sub-IndustryN/A Current SymbolNASDAQ:MDXH CIK1872529 Webmdxhealth.com Phone324-364-2070Fax32042597875Employees300Year Founded2003Price Target and Rating Average Price Target for MDxHealth$4.63 High Price Target$8.00 Low Price Target$1.50 Potential Upside/Downside+513.4%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage6 Analysts Profitability EPS (Trailing Twelve Months)($0.65) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$33.52 million Net Margins-29.90% Pretax Margin-32.79% Return on Equity-1,078.01% Return on Assets-22.51% Debt Debt-to-Equity RatioN/A Current Ratio1.63 Quick Ratio1.46 Sales & Book Value Annual Sales$110.97 million Price / Sales0.34 Cash FlowN/A Price / Cash FlowN/A Book Value($0.41) per share Price / Book-1.84Miscellaneous Outstanding Shares49,497,000Free Float48,656,000Market Cap$37.32 million OptionableNot Optionable Beta1.60 Social Links Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.Get This Free Report This page (NASDAQ:MDXH) was last updated on 5/28/2026 by MarketBeat.com Staff. From Our PartnersI paid $5,000 to hear Elon say thisOne investor paid $5,000 to be in a private room with Elon Musk in Los Angeles - and what he heard confirmed a...InvestorPlace | SponsoredA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredA 25,000% opportunityAngel investor Jason Calacanis - who made a fortune on an early Uber stake - says Elon Musk's latest project c...The Oxford Club | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredHidden on Tesla's filing: A $12 billion "super startup"Tesla's most recent SEC filing contains a single line showing $12 billion in revenue from a new venture Elon M...Banyan Hill Publishing | SponsoredWhen SpaceX goes public your retirement pays the priceWhen SpaceX files its S-1, institutions will liquidate holdings, rebalance portfolios, and free up capital for...Reagan Gold Group | SponsoredMassive Data Leak Exposes 512,000-Line Code That Could Change Society Forever"You won't believe what I discovered at 4 World Trade Center" When our financial media correspondent travel...Chaikin Analytics | SponsoredThe Iran War Just Broke the Gold MarketThe Iran war isn't just a geopolitical event. It's a financial one. Within hours of the strikes, oil surged...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MDxHealth SA Please log in to your account or sign up in order to add this asset to your watchlist. Share MDxHealth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
